Post

Lab studies have shown that psychedelics like psilocybin can lower inflammation and may be protective for a range of illnesses. Now, researchers are publishing some of the first data in humans that signals this holds potential for patients with neurodegenerative diseases like Parkinson's disease.

n.prNew human data hints at psychedelics' potential to combat inflammationLab studies have shown that psychedelics like psilocybin can lower inflammation and may be protective for a range of illnesses. Now, researchers are publishing some of the first data in humans that signals this holds potential for patients with neurodegenerative diseases like Parkinson's disease.

22/10/26, 7:41 pm89 reposts282 likes

hikeitup.bsky.social

@hikeitup.bsky.social

Outside of the physical benefits, I've often thought the world would be a MUCH better place if everyone tripped just once. Because that's all it takes to slow the ego.